Sign in
Back
Incidence, Mortality, and Cost Trends in Non-Ventilator Hospital-Acquired Pneumonia in Medicaid Beneficiaries, 2015-2019
Journal article   Peer reviewed

Incidence, Mortality, and Cost Trends in Non-Ventilator Hospital-Acquired Pneumonia in Medicaid Beneficiaries, 2015-2019

Karen K. Giuliano, Dian Baker, Madhuli Thakkar-Samtani, Michael Glick, Marcos I. Restrepo, Frank A. Scannapieco, Lisa J. Heaton and Julie Frantsve-Hawley
American journal of infection control
06/19/2022
DOI: https://doi.org/10.1016/j.ajic.2022.06.016
Handle:
https://hdl.handle.net/20.500.12741/rep:8508

Abstract

Non-ventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1000 patient days, mortality was 7.76%, with excess cost per NVHAP case of $20,189.

Metrics

1 Record Views

Details